VBI Vaccines Inc/BC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-07. The offering totals $7.0M, of which $7.0M was reported sold. Industry: Pharmaceuticals.
Showing 25 of 56 people.
| Name | Role | Location |
|---|---|---|
| Tomer Kariv | Director | Waltham, MA |
| Scott Requadt | Director | Louisville, KY |
| Nell E Beattie | Executive Officer | Cambridge, MA |
| Francisco E Diaz-Mitoma | Executive Officer | Cambridge, MA |
| Athena E Kartsaklis | Executive Officer | Cambridge, MA |
| Avi E Mazaltov | Executive Officer | Cambridge, MA |
| Christopher E McNulty | Executive Officer | Cambridge, MA |
| Steve Gillis | Director | New York, NY |
| Christopher McNulty | Director | Chicago, IL |
| Christopher McNulty | Executive Officer | Chicago, IL |
| Steven Gillis | Director | South San Francisco, CA |
| James Martin | Executive Officer | Radnor, PA |
| Steven Rubin | Director | Miami, FL |
| Sam Chawla | Director | Northbrook, IL |
| David Anderson | Executive Officer | Calgary, A0 |
| Adam Logal | Director | Framingham, MA |
| Damian R Braga | Director | Cambridge, MA |
| Joanne R Cordeiro | Director | Cambridge, MA |
| Blaine R McKee | Director | Cambridge, MA |
| Christopher R McNulty | Executive Officer | Cambridge, MA |
| Jeffrey R Baxter | Director | Cambridge, MA |
| Jeffrey R Baxter | Executive Officer | Cambridge, MA |
| Steven R Gillis | Director | Cambridge, MA |
| Michel R De Wilde | Director | Cambridge, MA |
| David E Anderson | Executive Officer | San Diego, CA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2022-09-28 | D | — | — |
| 2020-05-27 | D | $4.7M | $4.7M |
| 2020-05-01 | D | $1.1M | $1.1M |
| 2016-12-20 | D | $10.6M | $10.6M |
| 2016-07-05 | D | $13.6M | $13.6M |
| 2014-11-06 | D | $4.4M | $4.4M |
| 2010-09-10 | D | $275K | $275K |